baber/WOPTO huggingface dataset:
Patent FI-20060262-A0 (FI)
Inventor: KARHUMAEKI MARKKU
IPC: B21D/
Filed: 2006-03-20
Abstract: The bending apparatus of the invention has a body, with an opening (5) in it for the insertion of the plate (6), clamps for the holding of the plate (6), and a bending mechanism for the bending of the plate (6). The clamps (8) consist of holding clamps (A1, B1) and bending clamps (A2, B2), which are attached to each other with a flexible fixing agent (9), which bends and stretches as the plate (6) is bent.
Patent IL-100846-A0 (IL)
Title: Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
IPC: C07D333/26
Filed: 1992-02-02
Abstract: Certain novel hydroxamic acid and hydroxyurea derivatives having structure (I), wherein R<1> is hydrogen, alkyl, alkenyl, amino or substituted amino, R<4> is hydrogen, a pharmaceutically acceptable cation, aroyl or alkoyl, A is alkylene or alkenylene, X is oxygen or sulfur, each Y is hydrogen, halo, cyano, hydroxy, alkyl, alkoxy, alkylthio, alkenyl, alkoxyalkyl, cycloalkyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkoxy or substituted aryl, Z is oxygen or sulfur, m is 0 or 1, n is 1 to 5 and p is 2 to 6 inhibit the enzyme lipoxygenase. These compounds, and the pharmaceutically acceptable salts thereof, are useful in the treatment or alleviation of inflammatory diseases, allergic conditions and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.
Patent IL-121237-A0 (IL)
Title: Process and intermediates for preparing 2,3-disubstituted 4-hydroxyanilines
IPC: C07C215/76
Filed: 1997-07-04
Abstract: Preparation of a 2,3-di-substituted 4-hydroxyaniline of formula (I) comprises (a) reacting a 2,3-disubstituted phenol of formula (I) with a diazonium salt of formula (III) to give an azo compound of formula (IV); and (b) reducing (IV) to (I). X, Y = halo, alkoxy or CN; n = 0-5; Z = halo, alkyl, NO2, CN, COOH or SO3H; A<-> = a counter-ion. Intermediates (IV) are new.
Patent IL-122238-A0 (IL)
Title: Herbicidal composition comprising 4-iodo-2-[3-(4-methoxy-6- methyl-1,3,5-triazin-2-YL)ureidosulfonyl] benzoic esters
IPC: A01N43/40
Filed: 1996-06-05
Abstract: Herbicidal compositions comprising A) at least one compound from the group of the substituted phenylsulfonylureas of the formula I and their agriculturally acceptable salts in which R<SUP>1 </SUP>is (C<SUB>1</SUB>-C<SUB>8</SUB>)alkyl, (C<SUB>3</SUB>-C<SUB>4</SUB>)alkenyl, (C<SUB>3</SUB>-C<SUB>4</SUB>)alkynyl or (C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl which is mono- to tetrasubstituted by radicals selected from the group consisting of halogen and (C<SUB>1</SUB>-C<SUB>2</SUB>)alkoxy, and B) at least one herbicidally active compound from the group of compounds composed of Ba) herbicides which act selectively against grasses in cereals and/or maize, Bb) herbicides which act selectively against dicots in cereals and/or maize, Bc) herbicides which act selectively against grasses and dicots in cereals and/or maize and Bd) herbicides which act non-selectively against grass weeds and broad-leaved weeds in non-crop areas and/or selectively against grass weeds and broad-leaved weeds in transgenic crops.
Patent IL-129178-A0 (IL)
Title: Induction of nerve generation
IPC: A61P25/16
Filed: 1999-03-25
Abstract: Cyclic glycerophosphates and analogs thereof (CGs) are shown to exert neutral promoting activities in target cells. Such activities include promotion of neuronal outgrowth, promotion of nerve growth, provision of dopaminotrophic supporting envrionment in a diseased portion of the brain, prevention of nerve degeneration and nerve rescue. These activities of the CGs render them useful for treatment of various disorders including but not limited to mental disorders such as, for example, schizophrenia, dementia or disorders resulting in learning disablities. In addition, these CGs may be used for the treatment of neurodegenerative conditions such as Altzheimer's diesease, Parkinson's disease, conditions resulting from exposure to harmful environmental factors or resulting from a mechanical injury. The CGs may also be used to treat an individual suffering from a primary neurodengenerative condition in order to prevent or reduce the appearance of secondary degeneration in additional nerves ("nerve rescue").
Patent IL-132956-A0 (IL)
Title: Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism
IPC: A61K8/43
Filed: 1998-05-07
Abstract: An antiseptic cleansing composition comprising an antimicrobial agent, an effective amount of an alkylpolysaccharide surfactant, at least one alkyl alcohol and at least one aryl alcohol. Suitable surfactant alkylpolysaccharides may contain one or more sugar units selected from the group consisting of maltose, arabinose, xylose, mannose, galactose, gulose, idose, talose, allose, altrose, sucrose, fructose, sorbose, levulose, lactose, allulose, tagatose, alloheptulose, sedoheptulose, glucoheptulose, mannoheptulose, guloheptulose, idoheptulose, galactoheptulose, taloheptulose and derivatives thereof. Suitable antimicrobial agents include chlorhexidine, chlorhexidine salt, chlorophenol derivative, octenidindihydrochloride (CH<SUB>3</SUB>-(CH<SUB>2</SUB>)<SUB>7</SUB>-NHON-(CH<SUB>2</SUB>)<SUB>10</SUB>-NO-NH(CH<SUB>2</SUB>)<SUB>7</SUB>-CH<SUB>2 </SUB>or any other salt thereof, and quaternary ammonium compounds.
Patent IL-133277-A0 (IL)
Title: Ligands, including antibodies, showing reactivity against endocrine cells
IPC: C12N15/09
Filed: 1998-07-20
Abstract: The invention provides monoclonal and polyclonal antibodies recognising molecules on secretory cells of various tissue targets of autoimmune disease allowing a unifying method of preventing and treating autoimmune diseases and other conditions where hormonal dysregulation, hyperinsulinaemia and insulin resistance are involved. It also provides a method for detecting similar antibodies in human sera or other body fluids which can be used in the development of diagnostic kits. Treatment methods arising from this invention comprise the administration of preparations of the antibodies, their target molecules and vectors containing coding sequences of the antibodies and their target molecules.
Patent IL-140822-A0 (IL)
Title: Oxazolo, thiazolo and selenazolo (4,5-c) quinolin-4-amines and analogs thereof
IPC: A61K31/424
Filed: 1999-07-28
Abstract: Thiazolo-, oxazolo- and selenazolo[4,5-c]quinolin-4-amines and analogs thereof are described including methods of manufacture and the use of novel intermediates. The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the T-helper-type 2 immune response. The compounds are further useful in the treatment of viral and neoplastic diseases.
Patent IL-149643-A0 (IL)
Title: Method for anchoring a medical device between tissue
IPC: A61B17/00
Filed: 2002-05-14
Abstract: A method for implanting a medical device between tissue comprises the steps of providing a catheter having a body and a distal end thereof wherein the catheter includes an implantable device comprising a housing having a proximal end and a distal end and a longitudinal axis. The implantable device further includes a first set of anchoring members operatively connected to the proximal end of the housing and a second set of anchoring members operatively connected to the distal end of the housing. Both sets of anchoring members are movable between a collapsed position and a deployed position. Each set of anchoring members includes ring members connected to a housing of the device. Further steps of the method include inserting the distal end of the catheter into tissue and disposing the medical device at least partially from the distal end of the catheter. The first set of anchoring members are moved from the collapsed position to the deployed position and one side of the tissue is engaged with the tissue engaging surfaces of each ring member of the first set of anchoring member. The medical device is further disposed completely from the distal end of the catheter wherein the second set of anchoring members are moved from the collapsed position to the deployed position and the other side of the tissue is engaged with the tissue engaging surfaces of each ring member of the second set of anchoring members. <IMAGE>
Patent IL-150706-A0 (IL)
Title: Composition and methods for the treatment of skin disorders
Inventor: HAREL AVIKAM
IPC: A61K31/70
Filed: 2001-01-09
Abstract: Methods and pharmaceutical compositions for use in the treatment of a benign and/or a malignant proliferative pathologies are disclosed. The methods comprise administration of nicotinamide or its analogs and/or cADPR or its analogs, optionally in combination with a vitamin D3 analog or a Vitamin A analog.
Patent IL-151006-A0 (IL)
Title: Attitude estimation in tiltable body using modified quaternion data representation
IPC: G05D1/08
Filed: 2001-02-01
Abstract: The attitude of a tiltable body is tracked and controlled on the basis of signals outputted from gyros and tilt sensors. The signals outputted from the gyros are transformed and integrated to produce estimated position information in the form of a modified quaternion in which the yaw component is constrained to a zero value. Modified quaternion information in the same form is also generated from signals outputted from the tilt sensor and is used to detect and correct an error component in the estimated position information. Gyro drift is also corrected based on the output of the tilt sensor.
Patent IL-151461-A0 (IL)
Title: Pseudo-randomized infrared blurring array
IPC: G02B3/00
Filed: 2001-12-21
Abstract: An infrared blurring array is formed of a substrate having thereon a surface array of blurlets whose foci vary in distance from a nominal focal surface location, and/or whose optical phases at the nominal focal surface location vary, in a pseudorandom but deterministic manner. The substrate may be made of a material transmissive to a waveband of incident infrared energy, and the blurlets are refractive lenslets in the substrate, or the blurlets may be mirrorlets in a reflective substrate. The blurlets are surfaces each defined by a curvature and an axial offset from a nominal focal surface location. At least one, and preferably both, of the curvature and the axial offset of each blurlet is a value that is randomly selected from a set of values defined by a respective distribution, preferably a truncated distribution.
Patent IL-152321-A0 (IL)
Title: Device for separating the connecting end of a hypodermic needle from the tip of an injection instrument
IPC: A61M5/34
Filed: 2001-05-14
Abstract: The connecting end of the hypodermic needle is so designed that it can be attached to and then disconnected from the tip of an injection instrument by pressure, that is, an axial tractional force exerted between the said needle and the said injection instrument. The extraction device has an opening delimited by locking elements forming one piece with elastic pieces so as to allow its diameter to vary between a minimum diameter and a maximum diameter at least equal to the diameter of the said connecting end and at least one piece associated with the said locking elements for the purpose of converting an axial force exerted on the said piece into at least one radial component capable of being applied to the said elastic pieces so as to deform them radially in order to increase the diameter of the said opening when axial pressure is exerted by the said connecting end.
Patent IL-155308-A0 (IL)
Title: A method for measuring the concentration of impurities in nitrogen, hydrogen and oxygen by means of ion mobility spectrometry
IPC: G01N27/62
Filed: 2001-12-12
Abstract: A method for the quantitative analysis of the impurities content in nitrogen, hydrogen or oxygen by means of ion mobility spectrometry is described. The method involves using pure argon or a mixture, having no impurities, containing argon and the gas to be analyzed, as a counterflow gas in the separation zone of the ion mobility spectrometer.
Patent IL-159913-A0 (IL)
Title: Methods for preventing antipsychotic-induced weight gain
IPC: C07J43/00
Filed: 2002-07-22
Abstract: This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents capable of inhibiting the binding of cortisol to its receptors can be used in methods for preventing antipsychotic-induced weight gain. Mifepristone, a potent specific glucocorticoid receptor antagonist, can be used in these methods. The invention also provides a kit for preventing AP-induced weight gain in a human including a glucocorticoid receptor antagonist and instructional material teaching the indications, dosage and schedule of administration of the glucocorticoid receptor antagonist.
Patent IL-161812-A0 (IL)
Title: Apo2 ligand/trail formulations
IPC: A61P19/02
Filed: 2002-11-12
Abstract: The inventions include Apo2L/TRAIL formulations and methods of using such formulations. Lyophilized and crystal formulations of Apo-2L/TRAIL which are stable and have improved Apo2L/TRAIL trimer formation are provided. Methods of making Apo-2L/TRAIL formulations, as well as devices and kits containing such formulations are also provided.
Patent IL-180232-A0 (IL)
Title: A device for moving a body linearly between two predetermined positions
Filed: 2006-12-21
Abstract: The device (1) has electromagnets (5, 8) including cores (6, 9) movably integrated to a body (2) and arranged to have action axes (7, 10) on the body parallel to a linear trajectory (F), respectively. A permanent magnet (11) co-acts magnetically with the core (6) when the body is in its rest/safety position, and the electromagnet (8) is energized to displace the body to an unlocking position. A return spring (13) is associated with the body for displacing the body towards the rest/safety position when the electromagnet (8) is not energized.
Patent IL-188982-A0 (IL)
Title: Multilayered electrochemical energy storage device and method of manufacture
IPC: H01M50/463
Filed: 2008-01-23
Abstract: An energy storage device comprising one or more cells, wherein each cell is defined by a pair of electrodes and a separator placed therebetween, wherein each cell is bounded by two current collectors, the geometric form and size of said separator being identical to the form and size of said current collectors, and wherein in each cell, one electrode is printed on one of said two current collectors and the other electrode is printed on one face of the separator, the two electrodes being electronically insulated by means of said separator, and wherein the peripheral region of the separator, which surrounds the electrode printed thereon, is sealed.
Patent RO-128171-A0 (RO)
Title: System for management of transactions with transport vehicles, in particular ships, yachts
Inventor: POPA MIRCEA
IPC: G06Q30/00
Filed: 2012-08-21
Abstract: The invention relates to a system for the management of transactions with recreational transport vehicles, in particular ships, boats, yachts and the like, meant to be employed in the field of services and/or product delivery to the clients. According to the invention, the system consists of a network of clients () connected to the Internet by various communication networks, a network () of product suppliers/service providers consisting of recreational transport vehicles, a network () of virtual recreational transport vehicle exhibitions and a network () of data providers for data concerning the sold and real-time monitored vehicles, which interact by means of a main server () which is so configured that it is capable to transmit and/or receive communications to/from the above-mentioned networks (), including identity control data, such as ID and password, biometric data received from a biometric sensor (), on some server-computers () of the client network (), the recreational transport vehicle suppliers network (), the virtual recreational transport vehicle exhibition network (), the network () of data providers for data concerning the sold and real-time monitored vehicles and on the main server () there being implemented certain software.
Patent RO-128297-A0 (RO)
Title: Process for producing protein biopolymers from wet-white leather waste
Inventor: ZAINESCU GABRIEL
IPC: C05F1/00
Filed: 2012-08-23
Abstract: The invention relates to a process for producing a protein biopolymer from wet-white leather wastes used as fertilizer in agriculture. According to the invention, the process consists in mixing, in a first stage, 1000 g of leather waste, comprising titanium, with 5...10 l of water whereto there are added 7...10 % CaO or 2...5% MgO and 2...5% NaOH for 4...6 h, then the mixture is hydrolized in an autoclave, there adding 3...7% potassium hydroxide and 0.3...1% boric acid at 90...98°C for 2.5 ...5 h, then the hydrolysate is passed through a 0.5...1 mmmesh screen, there resulting a liquid part and a sludge part comprising 4...9 % titanium, after which, in the second stage, 500 g of leather waste are mixed with 300...500 g of titanium-containing sludge and are pre-treated with 5...10 l of water and 1.5...3 % MgO and 3...5 % NaOH, at room temperature for 4...6 h, finally there are added 2...5% edible starch and 0.5...1% enzymatic commercial product, containing lipase, cellulase, amylase and protease for 1...2 h at a temperature of 35...40°C, from which there results a protein polymer having 63...89% organic substance and 289...935 mg of nitric nitrogen/100 g of polymer and a pH of 7...7.8.
Patent RO-130860-A0 (RO)
Title: Earthquake anti-tragedy suitcase
Inventor: ROGOJINĂ TRAIAN
IPC: E04H9/02
Filed: 2015-08-14
Abstract: The invention relates to an earthquake-proof construction represented by a suitcase, which may be placed in apartment buildings, schools, hotels or in office buildings, meant to protect people against earthquakes, terrorist attacks or acts of war. According to the invention, the suitcase consists of two frames with panels on which some protection and resistance bars are mounted, between the two frames, on the exterior ends thereof, there being two resistance assemblies while, on the panels, some protective blades are mounted, after sheltering, the suitcase being equipped with an oxygen mask, medicines, food, water, a whistle, a hammer and a cell phone.
Patent AU-2003900848-A0 (AU)
Title: Cistern flushing device
IPC: F16K31/26
Filed: 2003-02-26
Abstract: A method and device for triggered discharge of a reservoir includes a primary float for producing a primary float force to open an outlet valve of the reservoir. The primary float force is releasably restrained to prevent opening of the outlet valve until triggering of a release commences discharge of the reservoir using potentially significantly less force than the force to required to lever open the outlet valve itself.
Patent MC-1627-A1 (MC)
Inventor: SUSUMU HONDA
IPC: C07K1/22
Filed: 1984-09-19
Abstract: An intact human immune interferon protein and a method for its extraction and purification is disclosed. This method permits the purification to homogeneity of intact recombinant human immune interferon using extraction of transformed microorganisms containing the interferon with a protease inhibitor, such as guanidine-HCl, and purification with monoclonal antibodies to immune interferon.
Patent IE-910418-A1 (IE)
Title: Purification of 1,1,1-tris(4'-hydroxyphenyl)ethane
IPC: C07C37/70
Filed: 1991-02-08
Abstract: A process for the purification of 1,1,1-tris(4 min -hydroxyphenyl)ethane by washing a crude admixture containing both it and impurities with a saturated solution of 1,1,1-tris(4 min -hydroxyphenyl)ethane in water and methanol; and isolating the washed crude admixture from the effluent and dissolving the washed crude admixture in methanol, and adding water and sodium borohydride to the dissolved, washed crude admixture to form a precipitate of 1,1,1-tris(4 min -hydroxyphenyl)ethane, and filtering the precipitate to form a resultant purified 1,1,1-tris(4 min -hydroxyphenyl)ethane and a filtrate. Another embodiment of the invention provides iteratively repeating the process by washing an additional crude admixture batch with the filtrate from a prior purification.
Patent MA-27760-A1 (MA)
Inventor: KEPKA STANLEY W
IPC: A61K47/14
Filed: 2005-10-11
Abstract: A dual action antifungal nail coat composition and method of use for ameliorating or preventing fungal infection of the nails, and onychomycosis, in particular, is disclosed. Composition embodiments in the form of one-coat type and two-coat type suitable for daily fungicidal regimens are disclosed. A preferred antifungal nail coat composition comprises an effective fungicidal amount of antifungal agent, a permeation enhancing amount of a substantially non-volatile, permeation enhancer, a film-forming amount of a hydrophilic polymer, and a pharmaceutically acceptable, volatile carrier. The composition provides a substantially water-soluble fungicidal coating on contacting a fungally susceptible or infected nail.
Patent MA-44927-A1 (MA)
Title: Tuyau d'irrigation
Inventor: ABED MASARWA
IPC: F16L11/06
Filed: 2017-10-24
Abstract: L'invention concerne un tuyau d'irrigation s'étendant le long d'un axe et pourvu d'une paroi de tuyau avec une partie base (55) et une pluralité d'éléments de renflement (1, 2) partant de la partie base.
Patent UY-23591-A1 (UY)
Inventor: REPINEC STEPHEN
IPC: C11D1/66
Filed: 1993-06-03
Abstract: A high foaming, nonionic surfactant based, light duty, liquid detergent with desirable cleansing properties and mildness to the human skin comprising three essential surfactants: a water soluble nonionic surfactant as the major active ingredient, in an amount in excess of 50% by weight of the total surfactant content; a supplemental amount of a water soluble, foaming, anionic surfactant excluding the ethoxylated alkyl ether sulfates; and a lesser amount of a water soluble, foaming zwitterionic betaine surfactant.
Patent UY-23603-A1 (UY)
Title: Un proceso para hacer 1-ciclopentilalquil aminas de utilidad para la sintesis de edulcorantes
Inventor: D'ANGELO LIHONG
IPC: C07K5/075
Filed: 1993-06-22
Abstract: Esta invención se refiere a un proceso para producir 1-ciclopentilalquil aminas, que son útiles para la síntesis de edulcorantes artificiales, donde el proceso incluye los pasos de reducir un N-bencilo-3-alquilo-2-azanorborn-5-ene en un solvente alquilalcohol más bajo en presencia de un ácido acético, formato de amonio, y un catalizador de metal de transición para la producción del mencionado producto. Es de alcance un proceso para producir un edulcorante artificial que comprende los pasos descritos anteriormente más los pasos de enriquecer una mezcla (R,S) de 1-ciclopentilalquil-amina para producir una mezcla enriquecida en S-enantiómero; el acoplamiento de un ácido de L-aspartilo-D-alfa-amino alcanoico con la 1-ciclopentilalquil-amina para producir un L-aspartilo-D-alfa-ácido amino alcanoico-1-ciclopentilalquil-amida protegida; y desproteger dicho compuesto para producir un edulcorante artificial de amida dipéptida. Ejemplo no limitante de un producto según la invención: N-bencilo-2-aza-3-metilo-biciclo[2.2.1] hept-5-ene.
Patent UY-26390-A1 (UY)
Title: Indolinonas sustituidas en posición 5, su preparación y su utilización como medicamentos
Inventor: ROTH GERALD JURGEN DR
Filed: 2000-10-11
Abstract: El presente invento se refiere a indolinonas sustituidas en posición 5 de la fórmula general (I) en la que R1 hasta R5 y X están definidos como en la reivindicación 1, sus isómeros y sus sales, especialmente sus sales fisiológicamente compatibles, que presentan valiosas propiedades farmacológicas, especialmente un efecto inhibidor sobre diferentes quinazas y complejos de ciclinas y CDK´s sobre tirosina-quinasa de receptores, así como sobre la proliferación de células de tumores, a medicamentos que contienen estos compuestos, a su utilización y a procedimientos para su preparación.